Exploration of suitable pharmacodynamic parameters for acarbose bioequivalence evaluation: A series of clinical trials with branded acarbose

Huang, J; Liu, WY; Yu, JJ; Yang, JB; Li, M; Zou, C; Guo, CX; Yang, XY; Yang, S; Xie, JL; Huang, ZJ; Chen, H; Pei, Q; Yang, GP

Yang, GP (corresponding author), Cent South Univ, Xiangya Hosp 3, Ctr Clin Pharmacol, 138 TongZiPo Rd, Changsha 410013, Hunan, Peoples R China.; Pei, Q (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Pharm, 138 TongZiPo Rd, Changsha 410013, Hunan, Peoples R China.; Yang, GP (corresponding author), Cent South Univ, Res Ctr Drug Clin Evaluat, 138 TongZiPo Rd, Changsha 410013, Hunan, Peoples R China.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020; 86 (11): 2225

Abstract

Aims To determine deficiencies in the Food and Drug Administration (FDA)'s guidance for assessing acarbose bioequivalence (BE) and to explore optimal ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索